Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004051701 | SCV002644452 | uncertain significance | not specified | 2022-04-10 | criteria provided, single submitter | clinical testing | The p.V174I variant (also known as c.520G>A), located in coding exon 2 of the GALNT12 gene, results from a G to A substitution at nucleotide position 520. The valine at codon 174 is replaced by isoleucine, an amino acid with highly similar properties. This amino acid position is conserved. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |